Insider Transactions in Q4 2020 at Odonate Therapeutics, Inc. (ODTC)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
169
+5.06%
|
$2,704
$16.32 P/Share
|
|
Dec 31
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+12.48%
|
$5,600
$16.32 P/Share
|
|
Dec 30
2020
|
Aaron I. Davis Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.75%
|
$1,700,000
$17.46 P/Share
|
|
Dec 30
2020
|
Boxer Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+1.75%
|
$1,700,000
$17.46 P/Share
|
|
Dec 29
2020
|
Craig A Johnson Director |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$51,000
$17.0 P/Share
|
|
Dec 29
2020
|
Aaron I. Davis Director |
BUY
Open market or private purchase
|
Indirect |
225,000
+3.93%
|
$3,825,000
$17.11 P/Share
|
|
Dec 28
2020
|
Aaron I. Davis Director |
BUY
Open market or private purchase
|
Indirect |
75,000
+1.4%
|
$1,200,000
$16.9 P/Share
|
|
Dec 28
2020
|
Boxer Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+2.66%
|
$5,100,000
$17.01 P/Share
|
|
Dec 23
2020
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
139,138
+0.45%
|
$2,087,070
$15.57 P/Share
|
|
Dec 22
2020
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
74,502
+0.24%
|
$1,043,028
$14.88 P/Share
|
|
Dec 21
2020
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
62,144
+0.4%
|
$870,016
$14.58 P/Share
|
|
Dec 15
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121
+3.88%
|
$1,452
$12.91 P/Share
|
|
Dec 15
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43
+2.0%
|
$516
$12.91 P/Share
|
|
Nov 30
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.35%
|
$144
$12.77 P/Share
|
|
Nov 30
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122
+4.07%
|
$1,464
$12.77 P/Share
|
|
Nov 30
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45
+2.14%
|
$540
$12.77 P/Share
|
|
Nov 13
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96
+2.71%
|
$1,152
$12.2 P/Share
|
|
Nov 13
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128
+4.44%
|
$1,536
$12.2 P/Share
|
|
Nov 13
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46
+2.23%
|
$552
$12.2 P/Share
|
|
Oct 30
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96
+2.79%
|
$1,152
$12.25 P/Share
|
|
Oct 30
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
127
+4.61%
|
$1,524
$12.25 P/Share
|
|
Oct 30
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46
+2.28%
|
$552
$12.25 P/Share
|
|
Oct 15
2020
|
John G Lemkey Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88
+2.63%
|
$1,144
$13.35 P/Share
|
|
Oct 15
2020
|
Joseph P O'Connell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117
+4.47%
|
$1,521
$13.35 P/Share
|
|
Oct 15
2020
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42
+2.14%
|
$546
$13.35 P/Share
|